Stealth BioTherapeutics Competitors and Similar CompaniesClear all

Oxford BioTherapeutics's competitors and similar companies include Orchard Therapeutics and Cogent Biosciences.
Oxford BioTherapeutics
Oxford BioTherapeutics
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
Orchard Therapeutics
Orchard Therapeutics
Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders.
Cogent Biosciences
Cogent Biosciences
Cogent Biosciences (formerly known as Unum Therapeutics) is a biotechnology company that designs precision therapies to treat genetically driven diseases.
Founding Date
Founding Date
2004
Founding Date
2015
Founding Date
2014
Type
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Milton, GB HQ
San Jose, US
Locations
London, GB HQ
Boston, US
Boston, US
Foster City, US
Menlo Park, US
Locations
Waltham, US HQ
Boulder, US
Employees
Employees
51
Employees
166
Employees
16419% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
380.1 m
Valuation ($)
1.3 b

Financial

Revenue (est.)
Revenue (est.)
£2.1m (FY, 2018)
Revenue (est.)
$22.7m (FY, 2022)
Revenue (est.)
N/A
Net income
Net income
(£6.5m) (FY, 2018)
Net income
($150.7m) (FY, 2022)
Net income
($192.4m) (FY, 2023)

Funding

Total funding raised
Total funding raised
$ 21.6m
Total funding raised
$ 310.7m
Total funding raised
$ 178.3m
For sources of this data, please see the company profile

View Company Profiles

Orchard Therapeutics
HQ
London, GB
Employees
166

Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders.

View company
Cogent Biosciences
HQ
Waltham, US
Employees
164↑ 19% increase

Cogent Biosciences (formerly known as Unum Therapeutics) is a biotechnology company that designs precision therapies to treat genetically driven diseases.

View company